| |
HCV Reinfection
|
| |
| |
Jules: Despite the risk for reinfection there is no reason to deny initial or repeat treatment for IDUs or MSM who are reinfected. Treatment for these at-risk groups is an opportunity to educate about the risk for reinfection, and regardless denying treatment is not appropriate, it is not the clinician's decision to deny treatment, it will only lead to a higher risk for increasing further transmissions.
HCV Reinfection
http://www.natap.org/2012/EASL/EASL_93.htm
http://www.natap.org/2012/EASL/PIIS1473309912700105.pdf
Mar 29, 2012 - Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. Jason Grebely
HCV reinfection incidence and treatment outcome among HIV-positive MSM in London
http://www.natap.org/2013/HCV/061713_01.htm
Hepatitis C Re-infection Among HIV+ MSM in London & Prisoners in Spain
http://www.natap.org/2013/IAS/IAS_101.htm
High incidence rate of HCV reinfection after treatment of acute HCV infection in HIV-infected MSM in Amsterdam
http://www.natap.org/2011/CROI/croi_120.htm
Infrequent Reinfection after Successful Treatment for Hepatitis C Virus Infection in Injection Drug Users
http://www.natap.org/2004/HCV/112904_02.htm
Frequent HCV reinfection and superinfection
in a cohort of injecting drug users in Amsterdam
In total, 93 different HCV infections were
identified: 59 initial infections, 11 reinfections, 22 superinfections
and 1 coinfection.
http://www.natap.org/2009/HCV/071509_01.htm
|
|
| |
| |
|
|
|
